BRCA Testing for Pancreatic Cancer in Ashkenazi Jews

Pancreatic Cancer Genetics

Recruiting Observational Study
Pancreatic Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Columbia University · Other
Who this trial is looking for

This trial is looking for patients with pancreatic cancer who are of Ashkenazi Jewish descent. Participants will be tested for specific genetic mutations to help with early screening and treatment options.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with pancreatic cancer.
  • I am of Ashkenazi Jewish descent.
  • I have been part of a specific pancreatic cancer registry.

You may not be able to join if

  • I cannot provide informed consent.
  • I am under 18 years old.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The aim of this study is to determine the frequency of the three most common BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2) genetic mutations that are commonly found in Ashkenazi Jewish patients with pancreatic cancer. Testing for BRCA1 and BRCA2 mutations in relatives of hereditary pancreatic cancer patients may have a significant impact; allowing for early screening, treatment, an…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with pancreatic cancer. * Patients are of Ashkenazi Jewish descent. * Patients have been Columbia Pancreatic Cancer Prevention Program Registry and Tissue Bank for High-Risk Individuals (IRB-AAAA6154). Exclusion Criteria: * Inability to provide informed co…
Contacts

Fay Kastrinos, MD

212-305-1021

fk18@columbia.edu

CONTACT

Vilma Rosario

212-305-6033

vr2222@columbia.edu

CONTACT